Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 211Leukemia, Myeloid, Acute 181Precursor Cell Lymphoblastic Leukemia-Lymphoma 162Leukemia 125Lymphoma, Non-Hodgkin 112Hodgkin Disease 102Leukemia, Lymphocytic, Chronic, B-Cell 99Multiple Myeloma 97Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91Lymphoma 88Myeloproliferative Disorders 87Lymphoma, Follicular 72Leukemia, Myelomonocytic, Chronic 72Leukemia, Myeloid, Chronic-Phase 71Lymphoma, Mantle-Cell 70Burkitt Lymphoma 67Leukemia, Myeloid, Accelerated Phase 65Primary Myelofibrosis 62Lymphoma, B-Cell, Marginal Zone 61Lymphoma, Large B-Cell, Diffuse 60Blast Crisis 53Anemia, Refractory, with Excess of Blasts 51Lymphoma, Large-Cell, Immunoblastic 50Congenital Abnormalities 50Neoplasms, Plasma Cell 47Myelodysplastic-Myeloproliferative Diseases 45Dendritic Cell Sarcoma, Interdigitating 41Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 38Graft vs Host Disease 38Leukemia, Biphenotypic, Acute 37

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × Cyclophosphamide × Myeloid × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡